Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Roche
Roche
Novo Nordisk's phase 3 data for hemophilia hopeful fail to shake off Pfizer's shadow
Fierce Biotech
Tue, 06/27/23 - 10:36 pm
Novo Nordisk
hemophilia
clinical trials
Pfizer
Roche
Hemlibra
Roche drops antisense drug after seeing efficacy data, leaving Biogen, Ionis and Ultragenyx to duke it out
Fierce Biotech
Fri, 06/23/23 - 09:46 am
Roche
Angelman Syndrome
antisense
Biogen
Ionis Pharmaceuticals
Ultragenyx
rugonersen
Late-stage pipeline for idiopathic pulmonary fibrosis is small but growing
Clinical Trials Arena
Mon, 06/19/23 - 11:39 am
IPF
Roche
Esbriet
Pirespa
Boehringer Ingelheim
Ofev
Roche follows AbbVie with FDA approval for dual-targeting lymphoma drug
BioPharma Dive
Fri, 06/16/23 - 09:57 am
Roche
Columvi
FDA
relapsed or refractory diffuse large B-cell lymphoma
blood cancer
Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices
BioSpace
Wed, 06/7/23 - 11:22 am
biosimilars
biologics
drug pricing
Roche
Herceptin
Amgen
Kanjinti
Viatris
Ogivri
Pfizer
Trazimera
Teva Pharmaceutical
Herzuma
Organon
Ontruzant
ASCO: Merck's Keytruda trips in EGFR lung cancer as Roche's Tecentriq fails in kidney cancer
Fierce Pharma
Tue, 06/6/23 - 04:19 pm
ASCO 2023
Merck
Keytruda
EGFR lung cancer
Roche
Tecentriq
kidney cancer
Nykode collaborates with Roche for an upcoming trial in cervical cancer
Clinical Trials Arena
Thu, 06/1/23 - 11:24 am
Nykode Therapeutics
Roche
cervical cancer
VB10.16
clinical trials
Roche looking to sell or shut down California biologic drug plant
Reuters
Thu, 06/1/23 - 11:21 am
Roche
Genentech
California
drug manufacturing
Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
BioSpace
Wed, 05/31/23 - 11:15 am
layoffs
Rain Oncology
Takeda
PTC Therapeutics
Affimed
Urovant Sciences
Roche
Novavax
Gossamer Bio
Bristol Myers Squibb
ADC Therapeutics
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
Roche Terminates Second Phase II Schizophrenia Trial
BioSpace
Tue, 05/23/23 - 11:24 am
Roche
schizophrenia
ralmitaront
clinical trials
Gilead picks former Roche executive to run cell therapy unit Kite
BioPharma Dive
Wed, 05/17/23 - 11:14 am
Gilead Sciences
Roche
Kite Pharma
cell therapy
Cindy Perettie
women executives
Roche’s BTK inhibitor succeeds in a Phase II MS trial
Clinical Trials Arena
Wed, 05/17/23 - 10:07 am
Roche
fenebrutinib
clinical trials
MS
relapsing multiple sclerosis
Big Pharma layoffs: BMS, Roche and Takeda axe hundreds of jobs
Medical Marketing and Media
Mon, 05/15/23 - 10:04 am
layoffs
Bristol Myers Squibb
Roche
Takeda
Gossamer Bio
Novavax
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
drug launches
AbbVie
Almirall
Apellis Pharmaceuticals
Astellas
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eli Lilly
Genmab
GSK
Iveric Bio
Pfizer
Roche
SAGE Therapeutics
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Vertex Pharmaceuticals
BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit
Yahoo/Reuters
Thu, 05/11/23 - 10:08 am
BioNTech
Roche
Genentech
pancreatic cancer
MRNA
Nature
vaccines
Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks
BioSpace
Wed, 05/10/23 - 10:18 am
Gilead Sciences
GSK
momelotinib
Roche
Eli Lilly
lebrikizumab
Merck
Zejula
Amgen
Galenica
Veltassa
Cubicin
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
AbbVie
Amgen
AstraZeneca
Bristol Myers Squibb
Daiichi Sankyo
Eli Lilly
Gilead Sciences
Horizon Therapeutics
Merck
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
FDA Accepts Application for Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)
BioSpace
Tue, 05/9/23 - 12:27 pm
Roche
Genentech
FDA
Vabysmo
macular edema
retinal vein occlusion
Roche, with HER2 franchise under pressure, pays $70M for breast cancer brain metastases prospect
Fierce Biotech
Tue, 05/9/23 - 11:39 am
Roche
Zion Pharma
brain metastases
breast cancer
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »